Comprehensive Summary: EUS-Guided Portal Pressure Measurement
Presented by Prof. Sanjaya Satapathy, MD | Transplant Hepatologist
1. Main Clinical Topics Discussed
- Pathophysiology and clinical significance of portal hypertension in chronic liver disease
- Limitations of the conventional hepatic venous pressure gradient (HVPG) measurement
- Endoscopic ultrasound (EUS)-guided portal pressure gradient (PPG) measurement: rationale, technique, equipment, and clinical evidence
- Safety considerations and future directions for EUS-guided portal pressure assessment
2. Key Learning Points, Guidelines, and Recommendations
Portal Hypertension Background:
- Defined by an increased pressure gradient between the portal vein and the inferior vena cava
- >90% of cases in Western countries are due to cirrhosis, with resistance at the sinusoidal level
- Major complications include ascites, varices, splenomegaly, and portosystemic shunting
- A hepatic venous pressure gradient (HVPG) ≥10–12 mmHg defines clinically significant portal hypertension (CSPH), the threshold beyond which risks of variceal bleeding, hepatic decompensation, and mortality increase substantially
HVPG — Current Gold Standard and Its Limitations:
- HVPG = Wedged hepatic venous pressure (WHVP) − Free hepatic venous pressure (FHVP)
- Normal HVPG: 1–5 mmHg
- Requires transjugular vascular access under fluoroscopic guidance (radiation exposure)
- Indirect measurement — does not directly measure portal venous pressure
- Inaccurate in pre-sinusoidal portal hypertension (e.g., non-cirrhotic portal hypertension)
- Limited to specialized tertiary centers; not easily integrated with routine endoscopy
EUS-Guided PPG — Emerging Alternative:
- Allows direct intravascular measurement of portal venous pressure in real time
- PPG = Portal vein pressure − Hepatic vein pressure
- Performed during a routine EUS examination — no fluoroscopy or transjugular access required
- Applicable across both sinusoidal and pre-sinusoidal disease processes
- Integrates portal pressure assessment seamlessly with standard endoscopic practice
3. Specific Clinical Data, Statistics, and Study Results
- Prospective, single-center comparative study (n = 30 patients) with chronic portal hypertension:
- Both HVPG and EUS-guided PPG measured in the same patients
- Intraclass Correlation Coefficient (ICC) = 0.82 — indicating good agreement between EUS-PPG and HVPG
- Bland-Altman analysis confirmed acceptable agreement across the range of measured pressures without significant systematic bias
- Conclusion: EUS-guided PPG correlates well with HVPG and may represent a valid alternative for portal hypertension assessment
4. Practical Takeaways for Clinicians
Equipment Required (largely familiar to endosonographers):
- Linear array echoendoscope
- 22- or 25-gauge EUS-FNA needle
- Compact pressure manometer or digital pressure transducer
- Non-compressible tubing system (prevents signal dampening)
- Saline flush system (maintains needle patency)
Procedural Workflow:
- Performed under conscious sedation or general anesthesia
- Echoendoscope positioned in stomach or duodenum for optimal liver/portal vein visualization
- Color Doppler used to confirm venous flow and distinguish portal vein from adjacent arterial structures — mandatory before vascular puncture
- Portal vein accessed via shortest, safest trajectory; bile ducts and intervening vessels carefully avoided
- Pressure waveforms confirmed for reproducibility before concluding measurement
- Hepatic vein identified separately; pressure recorded with the same transducer system
- PPG calculated from both measurements within a single EUS session
Vascular Identification Pearls:
- Portal vein: continuous monophasic waveform, low pulsatility on Doppler
- Hepatic vein: triphasic waveform (A, S